RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
G
Adamts13
ADAM metallopeptidase with thrombospondin type 1 motif, 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19260037
NCBI chr 3:10,299,264...10,338,464
Ensembl chr 3:10,300,028...10,346,687
G
Alb
albumin
ISO
RGD
PMID:6683982
RGD:11036083
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Cd40
CD40 molecule
ISO
protein:increased expression:peripheral blood, B lymphocyte (human)
RGD
PMID:17654056
RGD:11344977
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd40lg
CD40 ligand
treatment
ISO
protein:increased expression:peripheral blood, T lymphocyte (human) protein:decreased expression:serum (mouse)
RGD
PMID:17654056 PMID:22537155 PMID:18341638 PMID:16188945
RGD:11344977 , RGD:11352267 , RGD:11352237 , RGD:11344980
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
Cd86
CD86 molecule
treatment
ISO
protein:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:19379594 PMID:20581660
RGD:11354966 , RGD:11520785
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Dnmt3a
DNA methyltransferase 3 alpha
ISO
mRNA:decreased expression:mononuclear cell
RGD
PMID:18683034
RGD:9588662
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
G
Dnmt3b
DNA methyltransferase 3 beta
susceptibility
ISO
mRNA:decreased expression:mononuclear cell DNA:SNP:promoter: -579G>T(human)
RGD
PMID:18683034 PMID:23000068
RGD:9588662 , RGD:9589094
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
G
Fas
Fas cell surface death receptor
ISO
protein:increased expression:serum:
RGD
PMID:10776692
RGD:11049162
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fcgr2a
Fc gamma receptor 2A
no_association susceptibility treatment
ISO
DNA:SNP:cds:p.R131H (human)
RGD
PMID:20699442 PMID:23249566 PMID:22123287 PMID:21131591
RGD:11040883 , RGD:11040990 , RGD:11040989 , RGD:11040933
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
G
Fcgr2b
Fc gamma receptor 2B
treatment disease_progression
ISO
DNA:SNP: :p.I232T (human)
RGD
PMID:21131591 PMID:21045192 PMID:22257295 PMID:15566359 PMID:19549396
RGD:11040933 , RGD:11344955 , RGD:11344931 , RGD:11344928 , RGD:11344927
NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778
G
Fcgr3a
Fc gamma receptor 3A
treatment susceptibility
ISO
DNA:SNP:cds:p.V158F(human) DNA:SNP:exon:p.F158V (rs396991) (human)
RGD
PMID:11380443 PMID:23484707 PMID:22123287 PMID:15479722
RGD:11040776 , RGD:11352255 , RGD:11040989 , RGD:11344926
NCBI chr13:83,249,905...83,259,921
Ensembl chr13:83,249,872...83,259,921
G
Gp1ba
glycoprotein Ib platelet subunit alpha
ISO
RGD
PMID:16861348
RGD:10450841
NCBI chr10:55,352,938...55,355,804
Ensembl chr10:55,352,899...55,356,774
G
Il10
interleukin 10
disease_progression
ISO
DNA:SNP:promoter:-627C>A (human) DNA:SNPs, haplotypes:promoter:-1082A>G, -819C>T, -592C>A (human)
RGD
PMID:25051072 PMID:22677268
RGD:11041894 , RGD:11046267
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il18
interleukin 18
ISO
protein:increased expression:plasma:
RGD
PMID:24801815
RGD:11073600
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
ISO
DNA:SNP:promoter:-899C>T (human)
RGD
PMID:21591983
RGD:11051966
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1rn
interleukin 1 receptor antagonist
susceptibility
ISO
DNA:repeats::
RGD
PMID:20626741
RGD:11528541
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il2
interleukin 2
susceptibility
ISO
DNA:polymorphism::-330T>G(human)
RGD
PMID:20626741
RGD:11528541
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il4
interleukin 4
disease_progression
ISO
DNA:repeat:intron
RGD
PMID:25051072
RGD:11041894
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Itgb3
integrin subunit beta 3
ISO
RGD
PMID:10936026 PMID:24258817
RGD:10755473 , RGD:10755475
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
G
Mir130a
microRNA 130a
ISO
RNA:decreased expression:PBMC
RGD
PMID:24801815
RGD:11073600
NCBI chr 3:69,822,542...69,822,629
Ensembl chr 3:69,822,542...69,822,629
G
Mir3581
microRNA 3581
treatment
ISO
RGD
PMID:23360331
RGD:10755694
NCBI chr 6:128,757,779...128,757,858
Ensembl chr 6:128,757,779...128,757,858
G
Mir409
microRNA 409
treatment
ISO
RGD
PMID:23360331
RGD:10755694
NCBI chr 6:128,757,780...128,757,856
Ensembl chr 6:128,757,779...128,757,858
G
Plat
plasminogen activator, tissue type
ISO
protein:increased expression:plasma (human)
RGD
PMID:2129164
RGD:11541072
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Ptpn22
protein tyrosine phosphatase, non-receptor type 22
no_association
ISO
DNA: snp: cds: C1858T DNA:snp:cds:c.1858C>T (rs2476601) (human)
RGD
PMID:21597364 PMID:27309885
RGD:6484673 , RGD:11535019
NCBI chr 2:191,366,761...191,414,782
Ensembl chr 2:191,366,808...191,414,779
G
RT1-Bb
RT1 class II, locus Bb
treatment
ISO
DNA:polymorphisms:cds:HLA-DQB1*0401 (human)
RGD
PMID:10435723
RGD:11041758
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
RT1-Db1
RT1 class II, locus Db1
treatment
ISO
DNA:polymorphisms:cds:HLA-DRB1*0901, HLA-DRB1*0410 (human)
RGD
PMID:10435723
RGD:11041758
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
Socs1
suppressor of cytokine signaling 1
ISO
ClinVar Annotator: match by term: Autoimmune thrombocytopenia | ClinVar Annotator: match by term: Autoimmune thrombocytopenic purpura
ClinVar
PMID:32853638 PMID:33087723
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
G
Tgfb1
transforming growth factor, beta 1
disease_progression
ISO
mRNA:increased expression: : protein:decreased expression:plasma:
RGD
PMID:11886393 PMID:24763013 PMID:24801815
RGD:11073598 , RGD:11073603 , RGD:11073600
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Bivm
basic, immunoglobulin-like variable motif containing
ISO
ClinVar Annotator: match by term: Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency
ClinVar
PMID:25414442 PMID:28492532
NCBI chr 9:46,268,758...46,305,038
Ensembl chr 9:46,269,252...46,305,024
G
Ccdc168
coiled-coil domain containing 168
ISO
ClinVar Annotator: match by term: Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency
ClinVar
PMID:25414442 PMID:28492532
NCBI chr 9:46,198,234...46,236,325
Ensembl chr 9:46,198,635...46,235,936
G
Ercc5
ERCC excision repair 5, endonuclease
ISO
ClinVar Annotator: match by term: Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency
ClinVar
PMID:25414442 PMID:28492532
NCBI chr 9:46,309,477...46,354,478
Ensembl chr 9:46,309,389...46,354,472
G
Fgf14
fibroblast growth factor 14
ISO
ClinVar Annotator: match by term: Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency
ClinVar
PMID:25414442 PMID:28492532
NCBI chr15:101,045,033...101,679,888
Ensembl chr15:101,045,036...101,679,900
G
Mettl21c
methyltransferase 21C, AARS1 lysine
ISO
ClinVar Annotator: match by term: Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency
ClinVar
PMID:25414442 PMID:28492532
NCBI chr 9:46,130,451...46,145,128
Ensembl chr 9:46,134,001...46,145,112
G
Poglut2
protein O-glucosyltransferase 2
ISO
ClinVar Annotator: match by term: Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency
ClinVar
PMID:25414442 PMID:28492532
NCBI chr 9:46,256,388...46,268,714
Ensembl chr 9:46,256,390...46,268,532
G
Slc10a2
solute carrier family 10 member 2
ISO
ClinVar Annotator: match by term: Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency
ClinVar
PMID:25414442 PMID:28492532
NCBI chr16:84,386,528...84,409,475
Ensembl chr16:84,374,862...84,409,475
G
Tex30
testis expressed 30
ISO
ClinVar Annotator: match by term: Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency
ClinVar
PMID:25414442 PMID:28492532
NCBI chr 9:46,243,416...46,252,273
Ensembl chr 9:46,242,748...46,252,249
G
Tpp2
tripeptidyl peptidase 2
ISO
ClinVar Annotator: match by term: Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency
ClinVar
PMID:9536098 PMID:16199547 PMID:17576681 PMID:25414442 PMID:25640679 PMID:25741868 PMID:28492532 PMID:30533531 PMID:33583942 PMID:33586135 More...
NCBI chr 9:46,046,712...46,128,157
Ensembl chr 9:46,046,632...46,128,157
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all